Biogen Pharmachem Industries Share Price

CMP as on27-May-22 15:49

₹ 1.07
0.05 4.9%

Open

₹ 1.02

Turnover (lac)

₹ 5

Prev. Close

₹ 1.02

Day's Vol (shares)

₹ 21,32,212

Day's Range

₹ 1.02
₹ 1.07

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 19-May-2022 - -
Audited Results Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 25th May, 2022 at registered office of the company inter alia, to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2022. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking you.
Board Meeting - 25-Jan-2022 - -
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Saturday February 12 2022 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2021 also transact other business activities. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith un-audited financial result for quarter ended 31st December 2021. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated on 12.02.2022)
Board Meeting - 28-Oct-2021 - -
Quarterly Results In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2021. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 04-Aug-2021 - -
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Friday 13th August 2021 inter alia, to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2021. Please take the above intimation in your records. Thanking You, In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial results for quarter ended 30th June, 2021. Kindly take the same on your record and oblige. Thanking You. (As per BSE Announcement Dated on 13/8/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity